abstract |
The present invention relates to a novel crystalline form III, IV, V, VI and an amorphous form of clopidogrel hydrogen sulphate; and pharmaceutical compositions thereof, and methods of treating therewith. The invention further relates to novel processes for the preparation of these and forms I and II. SHE |